0001555192-22-000001.txt : 20220527 0001555192-22-000001.hdr.sgml : 20220527 20220527154136 ACCESSION NUMBER: 0001555192-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220527 DATE AS OF CHANGE: 20220527 EFFECTIVENESS DATE: 20220527 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Elicio Therapeutics, Inc. CENTRAL INDEX KEY: 0001555192 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 452966790 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-447361 FILM NUMBER: 22976742 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BUILDING 1400 WEST, SUITE 14303 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-209-0056 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BUILDING 1400 WEST, SUITE 14303 CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Vedantra Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20120730 D 1 primary_doc.xml X0708 D LIVE 0001555192 Elicio Therapeutics, Inc. 451 D STREET 5TH FLOOR, SUITE 501 BOSTON MA MASSACHUSETTS 02210 857-209-0050 DELAWARE Vedantra Pharmaceuticals, Inc. Corporation true Robert Connelly c/o Elicio Therapeutics, Inc. 451 D Street, 5th Floor, Suite 501 Boston MA MASSACHUSETTS 02210 Executive Officer Director Julian Adams c/o Elicio Therapeutics, Inc. 451 D Street, 5th Floor, Suite 501 Boston MA MASSACHUSETTS 02210 Director Daniel Geffken c/o Elicio Therapeutics, Inc. 451 D Street, 5th Floor, Suite 501 Boston MA MASSACHUSETTS 02210 Executive Officer Director Ofer Gonen c/o Elicio Therapeutics, Inc. 451 D Street, 5th Floor, Suite 501 Boston MA MASSACHUSETTS 02210 Director Robert Ruffolo c/o Elicio Therapeutics, Inc. 451 D Street, 5th Floor, Suite 501 Boston MA MASSACHUSETTS 02210 Director Carol Ashe c/o Elicio Therapeutics, Inc. 451 D Street, 5th Floor, Suite 501 Boston MA MASSACHUSETTS 02210 Director Daphne Karydas c/o Elicio Therapeutics, Inc. 451 D Street, 5th Floor, Suite 501 Boston MA MASSACHUSETTS 02210 Director Christopher Haqq c/o Elicio Therapeutics, Inc. 451 D Street, 5th Floor, Suite 501 Boston MA MASSACHUSETTS 02210 Executive Officer Annette Matthies c/o Elicio Therapeutics, Inc. 451 D Street, 5th Floor, Suite 501 Boston MA MASSACHUSETTS 02210 Executive Officer Biotechnology Decline to Disclose 06b false 2022-05-12 false true false 0 Finalis Securities LLC 305908 None None 228 Park Aveue South Suite 85550 New York NY NEW YORK 10003 All States false 50000000 974999 49025001 false 3 0 38250 true 0 true false Elicio Therapeutics, Inc. /s/ Robert Connelly Robert Connelly Chief Executive Officer 2022-05-27